Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, minerals and dietary supplements, feminine hygiene, diabetes care, scar management, and anti-parasite categories under the Good Sense, Sergeant's, Sentry, Zephrex D, PetArmor, and ScarAway brand names.
Read More…
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Phone353-1709-4000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$4.73 billion
Profitability
Miscellaneous
Employees10,600
Next Earnings Date2/27/2020 (Confirmed)
OptionableOptionable
Perrigo (NYSE:PRGO) Frequently Asked Questions
What is Perrigo's stock symbol?
Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."
How often does Perrigo pay dividends? What is the dividend yield for Perrigo?
Perrigo announced a quarterly dividend on Tuesday, February 18th. Investors of record on Friday, February 28th will be given a dividend of $0.225 per share on Tuesday, March 17th. This represents a $0.90 annualized dividend and a yield of 1.53%. This is a positive change from Perrigo's previous quarterly dividend of $0.21. View Perrigo's Dividend History.
How were Perrigo's earnings last quarter?
Perrigo Company PLC (NYSE:PRGO) announced its quarterly earnings results on Wednesday, November, 6th. The company reported $1.04 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.93 by $0.11. The business earned $1.19 billion during the quarter, compared to analysts' expectations of $1.20 billion. Perrigo had a net margin of 5.24% and a return on equity of 9.39%. The firm's revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.09 EPS. View Perrigo's Earnings History.
When is Perrigo's next earnings date?
How can I listen to Perrigo's earnings call?
Perrigo will be holding an earnings conference call on Thursday, February 27th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Perrigo issued on next quarter's earnings?
Perrigo updated its FY 2019
Pre-Market earnings guidance on Tuesday, January, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $4.797-4.797 billion, compared to the consensus revenue estimate of $4.77 billion.
What price target have analysts set for PRGO?
6 brokerages have issued 1 year target prices for Perrigo's shares. Their forecasts range from $48.00 to $70.00. On average, they anticipate Perrigo's stock price to reach $55.80 in the next year. This suggests that the stock has a possible downside of 5.3%. View Analyst Price Targets for Perrigo.
What is the consensus analysts' recommendation for Perrigo?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.
Has Perrigo been receiving favorable news coverage?
Media stories about PRGO stock have trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Perrigo earned a news impact score of -1.8 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Perrigo.
Who are some of Perrigo's key competitors?
Some companies that are related to Perrigo include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), AbbVie (ABBV), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), The Medicines (MDCO), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX) and Corcept Therapeutics (CORT).
What other stocks do shareholders of Perrigo own?
Who are Perrigo's key executives?
Perrigo's management team includes the folowing people:
- Mr. Murray S. Kessler, CEO, Pres & Director (Age 59)
- Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 59)
- Mr. Jeffrey R. Needham, Exec. VP & Pres of Consumer Healthcare Americas (Age 63)
- Mr. Svend Andersen, Exec. VP & Pres of Consumer Healthcare International (Age 57)
- Mr. Ronald L. Winowiecki, Advisory (Age 53)
Who are Perrigo's major shareholders?
Perrigo's stock is owned by a variety of of institutional and retail investors. Top institutional investors include State Street Corp (4.62%), Franklin Resources Inc. (4.49%), Parnassus Investments CA (2.20%), Sound Shore Management Inc. CT (2.00%), FMR LLC (1.93%) and Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.83%). Company insiders that own Perrigo stock include Geoffrey M Parker, Grainne Quinn, Jeffrey C Smith, Murray S Kessler, Ronald Craig Janish, Ronald Winowiecki, Svend Andersen, Theodore R Samuels II, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.
Which major investors are selling Perrigo stock?
PRGO stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Parnassus Investments CA, Manning & Napier Group LLC, Bank of Montreal Can, Sasco Capital Inc. CT, First Eagle Investment Management LLC, Phoenix Holdings Ltd. and First Trust Advisors LP. Company insiders that have sold Perrigo company stock in the last year include Grainne Quinn, Ronald Craig Janish, Ronald Winowiecki and Todd W Kingma. View Insider Buying and Selling for Perrigo.
Which major investors are buying Perrigo stock?
PRGO stock was purchased by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Diamond Hill Capital Management Inc., Great Lakes Advisors LLC, Jacobs Levy Equity Management Inc., Jane Street Group LLC, Alliancebernstein L.P., Magnetar Financial LLC and Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, Murray S Kessler, Svend Andersen, Theodore R Samuels II, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.
How do I buy shares of Perrigo?
Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Perrigo's stock price today?
One share of PRGO stock can currently be purchased for approximately $58.95.
How big of a company is Perrigo?
Perrigo has a market capitalization of $8.02 billion and generates $4.73 billion in revenue each year. The company earns $131 million in net income (profit) each year or $4.55 on an earnings per share basis. Perrigo employs 10,600 workers across the globe.View Additional Information About Perrigo.
What is Perrigo's official website?
How can I contact Perrigo?
Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]
MarketBeat Community Rating for Perrigo (NYSE PRGO)
MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote "Outperform" if you believe PRGO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRGO will underperform the S&P 500 over the long term. You may vote once every thirty days.
